SMARCA4 and malignant colon neoplasm: For the detailed mechanism study, we used in vivo and in vitro models to investigate the process by which BRG1 promotes VEGFC transcription, then induced the lymphangiogenesis in colon cancer cell lines and xenograft tumors.